Unhealthy Behaviours and All-Cause Mortality Among People With Chronic Hepatitis B, With and Without Hepatitis Delta (ANRS CO22 HEPATHER). [PDF]
Ramier C+9 more
europepmc +1 more source
One‐Pot Single‐Step Approach for the Controlled Synthesis of Multifunctional Microparticles
A versatile one‐pot strategy combines bipolar electrochemistry and the water‐organic interface to synthesize in a single‐step complex patchy particles, which cannot be achieved by any other deposition process. Under the influence of an electric field, microparticles undergo selective surface modification via coupled redox reactions, enabling ...
Bingbing Xie+7 more
wiley +1 more source
The PALLIA-TRAINING study: mixed-methods study to identify educational needs in palliative care among French oncology fellows. [PDF]
Dantigny R+7 more
europepmc +1 more source
Adaptive Epitaxy of C‐Si‐Ge‐Sn: Customizable Bulk and Quantum Structures
This work pushes the boundaries of epitaxy by achieving all‐group‐IV semiconductor heterostructures and extensive characterization. The alloys open new research topics in material properties investigation for next‐generation electronic and optoelectronic device technologies.
Omar Concepción+15 more
wiley +1 more source
Cross-border outbreak of <i>Yersinia enterocolitica</i> bioserotype 2/O:9 infections associated with consumption of French unpasteurised soft goat's milk cheese, 2024. [PDF]
Savin C+11 more
europepmc +1 more source
OptiNeoCare: optimisation of routine care in the management of severe perinatal asphyxia in full-term or near-term newborns - study protocol for analysis of suboptimal care by confidential inquiries and e-self report. [PDF]
Guellec I+21 more
europepmc +1 more source
Time-to-pregnancy in patients with previous breast cancer and unexposed women: a prospective exposed-unexposed cohort study. [PDF]
Hamy AS+30 more
europepmc +1 more source
Classification of GBA1 variants and their impact on Parkinson's disease: an in silico score analysis. [PDF]
Lanore A+34 more
europepmc +1 more source
Sunitinib as Second-Line Treatment in Advanced Intrahepatic Cholangiocarcinoma: Results From the SUN-CK GERCOR Phase II Trial. [PDF]
Gros L+16 more
europepmc +1 more source